Company page

Egetis Therapeutics Ab

Egetis Therapeutics Ab is a public company listed on the Swedish market under the ticker EGTX. The company has a market capitalization of approximately 299.6 million SEK. Egetis focuses on developing innovative therapies for rare diseases, aiming to improve patient outcomes through its specialized treatments.